Aram S. A. van Brussel

The potential of hypoxia markers as target for breast molecular imaging – a systematic review and meta-analysis of human marker expression

P. V. van Diest, E. van der Wall, S. Elias, 2013, BMC Cancer.

Expression of nuclear FIH independently predicts overall survival of clear cell renal cell carcinoma patients.

P. V. van Diest, J. Bosch, S. Kroeze, 2010, European journal of cancer.

Treatment of late-stage syphilis.

Aram S. A. van Brussel, G. W. Landman, 2015, JAMA.

Hypoxia-Targeting Fluorescent Nanobodies for Optical Molecular Imaging of Pre-Invasive Breast Cancer

W. Mali, P. V. van Diest, E. van der Wall, 2015, Molecular Imaging and Biology.

Genetic analysis of von Hippel‐Lindau disease

A. V. D. van den Ouweland, E. Voest, R. Giles, 2010, Human mutation.

Immunophenotyping invasive breast cancer: paving the road for molecular imaging

P. Bult, P. V. van Diest, E. van der Wall, 2012, BMC Cancer.

Near-Infrared Fluorescence Molecular Imaging of Ductal Carcinoma In Situ with CD44v6-Specific Antibodies in Mice: A Preclinical Study

W. Mali, P. V. van Diest, E. van der Wall, 2012, Molecular Imaging and Biology.

Optical imaging of pre-invasive breast cancer with a combination of VHHs targeting CAIX and HER2 increases contrast and facilitates tumour characterization

Sabrina Oliveira, W. Mali, P. V. van Diest, 2016, EJNMMI Research.